Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 11 | $2.49 | $2.65 | $2.58 |
Q2 2025 | 5 | $2.68 | $2.68 | $2.68 |
Q3 2025 | 6 | $2.69 | $2.69 | $2.69 |
Q4 2025 | 9 | $2.51 | $2.51 | $2.51 |
Q1 2026 | 4 | $2.62 | $2.62 | $2.62 |
Q2 2026 | 4 | $2.73 | $2.73 | $2.73 |
Q3 2026 | 6 | $2.78 | $2.78 | $2.78 |
Q4 2026 | 9 | $2.96 | $2.96 | $2.96 |
Q1 2027 | 4 | $2.87 | $2.87 | $2.87 |
Q2 2027 | 4 | $3.20 | $3.20 | $3.20 |
Q3 2027 | 7 | $3.22 | $3.22 | $3.22 |
Q4 2027 | 4 | $3.80 | $3.80 | $3.80 |
Johnson & Johnson last posted its earnings results on Wednesday, January 22nd, 2025. The company reported $2.04 earnings per share for the quarter, topping analysts' consensus estimates of $1.99 by $0.05. The company had revenue of 22.52 B for the quarter and had revenue of 88.82 B for the year. Johnson & Johnson has generated $6 earnings per share over the last year ($5.79 diluted earnings per share) and currently has a price-to-earnings ratio of 25.96. Johnson & Johnson has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 15th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
02/13/2025 | Q4 2024 | N/A | $1.43 | N/A | $22.43 B | $22.52 B |
10/23/2024 | Q3 2024 | N/A | $1.12 | N/A | $22.17 B | $22.47 B |
07/25/2024 | Q2 2024 | N/A | $1.95 | N/A | N/A | $22.45 B |
05/01/2024 | Q1 2024 | N/A | $2.20 | N/A | N/A | $21.38 B |
02/16/2024 | Q4 2023 | N/A | $1.68 | N/A | N/A | $21.40 B |
10/27/2023 | Q3 2023 | N/A | $10.32 | N/A | N/A | $21.35 B |
07/31/2023 | Q2 2023 | N/A | $1.98 | N/A | N/A | $21.52 B |
04/28/2023 | Q1 2023 | N/A | -$0.03 | N/A | N/A | $20.89 B |
02/16/2023 | Q4 2022 | N/A | $1.35 | N/A | N/A | $23.71 B |
10/27/2022 | Q3 2022 | N/A | $1.70 | N/A | N/A | $20.00 B |
07/29/2022 | Q2 2022 | N/A | $1.83 | N/A | N/A | $24.02 B |
04/29/2022 | Q1 2022 | N/A | $1.96 | N/A | N/A | $23.43 B |
02/17/2022 | Q4 2021 | N/A | $1.80 | N/A | N/A | $24.80 B |
10/29/2021 | Q3 2021 | N/A | $1.39 | N/A | N/A | $23.34 B |
07/29/2021 | Q2 2021 | N/A | $2.38 | N/A | N/A | $23.31 B |
04/30/2021 | Q1 2021 | N/A | $2.35 | N/A | N/A | $22.32 B |
02/22/2021 | Q4 2020 | N/A | $0.66 | N/A | N/A | $22.48 B |
10/23/2020 | Q3 2020 | N/A | $1.35 | N/A | N/A | $21.08 B |
07/24/2020 | Q2 2020 | N/A | $1.38 | N/A | $17.61 B | $18.34 B |
04/29/2020 | Q1 2020 | N/A | $2.20 | N/A | N/A | $20.69 B |
Johnson & Johnson has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 15th, 2025 based offlast year's report dates.
In the previous quarter, Johnson & Johnson (:JNJ) reported $2.04 earnings per share (EPS) to beat the analysts' consensus estimate of $1.99 by $0.05.
The conference call for Johnson & Johnson's latest earnings report can be listened to online.
The conference call transcript for Johnson & Johnson's latest earnings report can be read online.
Johnson & Johnson (:JNJ) has a recorded annual revenue of $88.82 B.
Johnson & Johnson (:JNJ) has a recorded net income of $14.07 B.Johnson & Johnson has generated $5.84 earnings per share over the last four quarters.
Johnson & Johnson (:JNJ) has a price-to-earnings ratio of 25.96 and price/earnings-to-growth ratio is -7.22.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED